MeSH tree: E01.789.800.190
An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers. The ...
Oct 24, 2026
0
109
Colon and rectal cancer often spread to the liver. In some patients, the metastases can be surgically removed or destroyed using local treatment with the aim of curing the disease. Despite this, the cancer often returns. ...
Sep 29, 2026
0
9
Atypical meningiomas are tumors that originate in the meninges and are associated with a high risk of recurrence. Until now, it was unclear whether patients benefit from radiotherapy after complete surgical removal of the ...
Sep 25, 2026
0
8
An exploratory 8-year landmark update from the Phase III ADAURA trial showed that adjuvant osimertinib continued to provide a long-term overall survival benefit for patients with completely resected, EGFR-mutated stage IB–IIIA ...
Sep 13, 2026
0
6
Mayo Clinic researchers have found that artificial intelligence (AI)-enabled spatial analysis can identify patterns in routine pathology slides that may help clinicians identify which patients with pancreatic cancer are at ...
Sep 11, 2026
0
5
Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors responded to neoadjuvant immunochemotherapy (ICT) and who underwent less extensive surgery had high disease-free survival and organ ...
Sep 10, 2026
0
11
Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) with moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate-risk ...
Aug 25, 2026
0
9
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
Jul 6, 2026
0
6
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
8
A new Northwestern Medicine study suggests that a simple blood test could help identify which patients with head and neck cancer will be most likely to benefit from immunotherapy, according to a study published in the Journal ...
Jun 8, 2026
0
4
